CME Group Inc. (CME) financial statements and ratios from SEC XBRL: revenue $6.52B (TTM), net margin 62.5%, revenue growth 0.8% YoY, P/E 22.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $6.52B |
| Net Margin | 62.5% |
| Revenue Growth (YoY) | 0.8% |
| EPS Growth (YoY) | 2.8% |
| FCF Growth (YoY) | -11.2% |
| P/E Ratio | 22.8 |
| EV / EBITDA | -13.8 |
| Price / Book | 3.69 |
| Price / Sales | 14.45 |
| FCF Yield | 4.3% |
| DCF Value (model) | $240.77 |
| DCF Upside vs Price | -11.1% |
| Altman Z-Score | 0.52 (distress) |
| Sector P/E (Financials) | 15.1 |
CME overview · CME earnings · CME KPIs · CME investor relations · CME ownership · CME peers · CME filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.